alkenes has been researched along with Colitis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dan, S; Hattori, T; Naito, M; Nishikawa, K; Ohashi, Y; Shiina, I; Watanabe-Takahashi, M; Yamori, T | 1 |
1 other study(ies) available for alkenes and Colitis
| Article | Year |
|---|---|
M-COPA, a novel Golgi system disruptor, suppresses apoptosis induced by Shiga toxin.
Topics: ADP-Ribosylation Factor 1; Alkenes; Antidotes; Apoptosis; Colitis; Diarrhea; Golgi Apparatus; Humans; Naphthols; Pyridines; Shiga Toxin; Shiga-Toxigenic Escherichia coli | 2016 |